Nobaxin (Azithromycin)

• Azithromycin is a macrolide antibiotic used to treat bacterial infections in the respiratory, ENT, skin and genitourinary systems.
• Community‑acquired pneumonia: reduces bacterial load and improves clinical symptoms in adults and children.
• Acute bacterial sinusitis: alleviates sinus inflammation and clears pathogenic bacteria.
• Acute bacterial pharyngitis/tonsillitis: shortens disease duration and relieves throat pain.
• Acute otitis media: eradicates middle‑ear pathogens and restores hearing function.
• Skin and soft‑tissue infections: eliminates causative organisms and promotes wound healing.
• Uncomplicated genital chlamydia infection: clears Chlamydia trachomatis and prevents transmission.

• Azithromycin binds to the 50S subunit of bacterial ribosomes, blocking the translocation step of protein synthesis. This inhibition prevents elongation of the peptide chain, leading to a bacteriostatic effect against susceptible Gram‑positive, Gram‑negative and atypical organisms. The drug’s high tissue penetration and long half‑life support sustained antimicrobial activity after short dosing courses.

Azithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate stomach upset experienced after oral intake.
• Diarrhea: loose stools that may be watery or contain mucus.
• Abdominal pain: cramping or discomfort in the lower abdomen.
• Headache: transient mild to moderate head pain.
• Altered taste: temporary metallic or bitter sensation.

Serious or Rare Side Effects

• QT prolongation: potential cardiac arrhythmias, especially in patients with pre‑existing heart conditions.
• Severe allergic reactions: including anaphylaxis, angioedema and skin rash.
• Hepatotoxicity: elevated liver enzymes or, rarely, clinically significant liver injury.
• Clostridioides difficile colitis: severe diarrhea due to overgrowth of C. difficile.
• Stevens‑Johnson syndrome: rare but life‑threatening mucocutaneous reaction.

• Before prescribing Nobaxin, clinicians should consider several precautionary measures to ensure patient safety.
• Cardiac assessment: evaluate risk of QT prolongation, especially in patients with known arrhythmias or electrolyte disturbances.
• Liver function: monitor hepatic enzymes in patients with pre‑existing liver disease.
• Drug interactions: review concomitant medications that may affect azithromycin metabolism or cardiac rhythm.
• Pregnancy and lactation: weigh potential benefits against unknown risks; use only if clearly indicated.
• Allergy history: avoid in patients with known hypersensitivity to macrolides.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Azithromycin interacts with several medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid)

• QT‑prolonging agents: avoid co‑administration with drugs such as quinidine, sotalol or certain anti‑arrhythmics.
• Antacids containing aluminum or magnesium: may reduce azithromycin absorption; separate dosing by at least 2 hours.
• Warfarin: azithromycin can increase INR; monitor coagulation parameters closely.

Moderate Interactions (Monitor Closely)

• Statins (e.g., simvastatin, atorvastatin): increased risk of myopathy; consider dose adjustment.
• Oral contraceptives: azithromycin may reduce efficacy; advise additional contraceptive measures.
• HIV protease inhibitors (e.g., ritonavir): may increase azithromycin levels; monitor for toxicity.